A Pharmaceutical Composition Comprising Metamizole, Drotaverine, And Caffeine

Patent No. EP3749286 (titled "A Pharmaceutical Composition Comprising Metamizole, Drotaverine, And Caffeine") was filed by Adamed Pharma on Feb 2, 2019. The application was issued on Oct 23, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MEDITOP GYOGYSZERIPARI KFTJul 21, 2025KOVARI

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3749286

ADAMED PHARMA
Application Number
EP19702616A
Filing Date
Feb 2, 2019
Status
Granted And Under Opposition
Sep 19, 2024
Publication Date
Oct 23, 2024